Viewing data from:

DICLOFENAC POTASSIUM

ANDA

DICLOFENAC POTASSIUM | A204648 | BIONPHARMA INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: ZIPSOR(TE code: AB)

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
DEPOMED, INC. v. BANNER PHARMACAPS INC. et al 2:2013cv04542 5 patentsANDA 204648diclofenac potassium	D.N.J.	2013-07-26	Terminated 2015-08-21	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

API Supply Chain7 active DMFs4 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

YUNG ZIP CHEMICAL IND CO LTDDICLOFENAC POTASSIUM

DMF 108311994

OLON SPADICLOFENAC POTASSIUM

DMF 112671994

SYN-TECH CHEM AND PHARM CO LTDDICLOFENAC POTASSIUM USP

DMF 126561997

DIPHARMA FRANCIS SRLDICLOFENAC POTASSIUM

DMF 130451998

UNIQUE CHEMICALSDICLOFENAC POTASSIUM USP

DMF 150742000

AMOLI ORGANICS PRIVATE LTDDICLOFENAC POTASSIUM USP

DMF 230282009

HENAN DONGTAI PHARM CO LTDDICLOFENAC POTASSIUM

DMF 305152016

CHENG FONG CHEMICAL CO LTDInactiveDICLOFENAC POTASSIUM

DMF 119901996

ESTEVE QUIMICA SAInactiveDICLOFENAC POTASSIUM

DMF 120211996

FARCHEMIA SRLInactiveDICLOFENAC POTASSIUM

DMF 122171996

CAMBREX PROFARMACO CORK LTDInactiveDICLOFENAC POTASSIUM

DMF 139341999

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 25MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Feb 23, 2016

No patent or exclusivity listings for this strength.